000 01349nam  2200277za 4500
0019.629655
003CaOODSP
00520160421104939
007cr |||||||||||
008150407s2015    xxc    go    f000 0 eng d
020 |a978-1-100-23447-2
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP40-125/2014E-PDF
24500|aUpdate on quadrivalent meningococcal vaccines available in Canada |h[electronic resource].
2461 |iAt head of title: |aAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
260 |aOttawa : |bPublic Health Agency of Canada, |c2015.
300 |a77 p. : |btables, graphs.
500 |aIssued also in French under title: Mise à jour sur l'utilisation des vaccins quadrivalents contre le méningocoque au Canada.
500 |a"April 2015."
500 |aAlso available in French under title: Mise à jour sur l’utilisation des vaccins quadrivalents contre le méningocoque au Canada.
504 |aIncludes bibliographical references.
6920 |2gccst|aImmunization
7101 |aCanada.|bPublic Health Agency of Canada.
77508|tMise à jour sur l'utilisation des vaccins quadrivalents contre le méningocoque au Canada |w(CaOODSP)9.677247
85640|qPDF|s1.70 MB|uhttp://publications.gc.ca/collections/collection_2015/aspc-phac/HP40-125-2014-eng.pdf